Joint (NASDAQ:JYNT) Stock Price Crosses Above 50-Day Moving Average – Should You Sell?

The Joint Corp. (NASDAQ:JYNT) shares crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $11.24 and traded as high as $11.38. Joint shares last traded at $11.34, with a volume of 18,578 shares changing hands.

Joint Trading Up 1.3 %

The firm has a market cap of $169.81 million, a PE ratio of -15.12 and a beta of 1.57. The firm has a fifty day simple moving average of $11.24 and a two-hundred day simple moving average of $13.01.

Joint (NASDAQ:JYNT) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Joint had a negative net margin of 12.00% and a positive return on equity of 2.17%. The company had revenue of $30.26 million during the quarter, compared to the consensus estimate of $29.65 million. Equities analysts expect that The Joint Corp. will post 0.13 earnings per share for the current fiscal year.

Institutional Trading of Joint

Several large investors have recently bought and sold shares of JYNT. JCP Investment Management LLC raised its holdings in Joint by 15.3% in the first quarter. JCP Investment Management LLC now owns 112,800 shares of the company’s stock worth $1,473,000 after purchasing an additional 15,000 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Joint by 8.9% during the first quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company’s stock valued at $1,177,000 after acquiring an additional 7,375 shares in the last quarter. First Foundation Advisors boosted its stake in Joint by 18.8% in the 1st quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock worth $2,733,000 after purchasing an additional 33,104 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Joint by 5.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock valued at $229,000 after purchasing an additional 837 shares during the last quarter. Finally, Ancora Advisors LLC increased its stake in Joint by 105.0% during the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock valued at $1,296,000 after purchasing an additional 50,815 shares in the last quarter. 76.88% of the stock is owned by institutional investors.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.